Alamar Biosciences, Inc. (California) (ALMR)

34.36 +1.90 (+5.85%) USD  |  NASDAQ  |  Oct 02, 16:00
34.62 +0.26 (+0.76%) After-Hours: 20:00
More

Alamar Biosciences Cash from Operations (TTM) : -56.62M for June 30, 2026

Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2026. Start Trial.
Date Value
June 30, 2026 -56.62M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

View Cash from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (TTM) Benchmarks

View Cash from Operations (TTM) Benchmarks
Start Trial
10X Genomics, Inc. 127.08M
Personalis, Inc. -92.30M
Adaptive Biotechnologies Corp. -21.01M
Champions Oncology, Inc. -5.564M
Medpace Holdings, Inc. 752.66M